Xencor, Inc Interest Income, Other
Xencor, Inc (XNCR) reported Interest Income, Other of $9.10 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2019-02-26
- Xencor, Inc interest income, other for the quarter ending 2018-06-30 was $2.49M, a 139.50% increase year-over-year.
- Xencor, Inc interest income, other for the quarter ending 2018-03-31 was $1.16M, a 9.56% increase year-over-year.
- Xencor, Inc interest income, other for the quarter ending 2017-12-31 was $1.05M, a 34.01% increase year-over-year.
- Xencor, Inc interest income, other for the quarter ending 2017-09-30 was $1.05M, a 81.00% increase year-over-year.
- Xencor, Inc interest income, other for fiscal 2018 was $9.10M, a 117.02% increase from fiscal 2017.
- Xencor, Inc interest income, other for fiscal 2017 was $4.19M, a 100.57% increase from fiscal 2016.
- Xencor, Inc interest income, other for fiscal 2016 was $2.09M, a 181.05% increase from fiscal 2015.
- Xencor, Inc interest income, other for fiscal 2015 was $744.00K, a 2154.55% increase from fiscal 2014.
| Period end | Interest Income, Other 3 month | Interest Income, Other 3 month as first filed | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 9 month as first filed | Interest Income, Other 12 month | Interest Income, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $9.10M 10-K · filed 2019-02-26 | ||||||
| 2018-06-30 | $2.49M 10-Q · filed 2018-08-07 | $3.64M 10-Q · filed 2018-08-07 | $4.70M derived: sum of 3 quarters · filed 2019-02-26 | $5.74M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2018-03-31 | $1.16M 10-Q · filed 2018-05-07 | $2.21M derived: sum of 2 quarters · filed 2019-02-26 | $3.26M derived: sum of 3 quarters · filed 2019-02-26 | $4.30M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.10M derived: sum of 2 quarters · filed 2019-02-26 | $3.14M derived: sum of 3 quarters · filed 2019-02-26 | $4.19M 10-K · filed 2019-02-26 | |||
| 2017-09-30 | $1.05M 10-Q · filed 2018-11-05 | $2.09M derived: sum of 2 quarters · filed 2018-11-05 | $3.14M 10-Q · filed 2018-11-05 | $3.93M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $1.04M 10-Q · filed 2018-08-07 | $2.10M 10-Q · filed 2018-08-07 | $2.88M derived: sum of 3 quarters · filed 2019-02-26 | $3.46M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $1.06M 10-Q · filed 2018-05-07 | $1.84M derived: sum of 2 quarters · filed 2019-02-26 | $2.42M derived: sum of 3 quarters · filed 2019-02-26 | $2.79M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.36M derived: sum of 2 quarters · filed 2019-02-26 | $1.73M derived: sum of 3 quarters · filed 2019-02-26 | $2.09M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $579.00K 10-Q · filed 2017-11-08 | $947.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.31M 10-Q · filed 2017-11-08 | $1.63M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $368.00K 10-Q · filed 2017-08-07 | $726.00K 10-Q · filed 2017-08-07 | $1.05M derived: sum of 3 quarters · filed 2018-02-28 | $1.32M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $359.00K 10-Q · filed 2017-05-10 | $678.00K derived: sum of 2 quarters · filed 2018-02-28 | $952.00K derived: sum of 3 quarters · filed 2018-02-28 | $1.24M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $593.00K derived: sum of 2 quarters · filed 2018-02-28 | $883.00K derived: sum of 3 quarters · filed 2018-02-28 | $744.00K 10-K · filed 2018-02-28 | $1.84M 10-K · filed 2016-03-08 | ||
| 2015-09-30 | $274.00K 10-Q · filed 2016-11-02 | $676.00K 10-Q · filed 2015-11-04 | $564.00K derived: sum of 2 quarters · filed 2016-11-02 | $425.00K 10-Q · filed 2016-11-02 | $1.07M 10-Q · filed 2015-11-04 | $604.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $290.00K 10-Q · filed 2016-08-03 | $391.00K 10-Q · filed 2016-08-03 | $330.00K derived: sum of 3 quarters · filed 2017-03-01 | $332.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $38.00K 10-Q · filed 2016-05-02 | $101.00K 10-Q · filed 2015-05-05 | $40.00K derived: sum of 2 quarters · filed 2017-03-01 | $42.00K derived: sum of 3 quarters · filed 2017-03-01 | $53.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.00K derived: sum of 2 quarters · filed 2017-03-01 | $15.00K derived: sum of 3 quarters · filed 2017-03-01 | $33.00K 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-04 | $13.00K derived: sum of 2 quarters · filed 2015-11-04 | $31.00K 10-Q · filed 2015-11-04 | $38.00K derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-06-30 | $11.00K 10-Q · filed 2015-08-05 | $29.00K 10-Q · filed 2015-08-05 | $36.00K derived: sum of 3 quarters · filed 2016-03-08 | $40.00K derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-03-31 | $18.00K 10-Q · filed 2015-05-05 | $25.00K derived: sum of 2 quarters · filed 2016-03-08 | $29.00K derived: sum of 3 quarters · filed 2016-03-08 | $31.00K derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2013-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $11.00K derived: sum of 2 quarters · filed 2016-03-08 | $13.00K derived: sum of 3 quarters · filed 2016-03-08 | $14.00K 10-K · filed 2016-03-08 | |||
| 2013-09-30 | $4.00K 10-Q · filed 2014-11-10 | $6.00K derived: sum of 2 quarters · filed 2014-11-10 | $7.00K 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-01 | $3.00K 10-Q · filed 2014-08-01 | |||||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $11.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |